Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Descriptive Epidemiology of Neurodegenerative Diseases: What Are the Critical Questions?
Giancarlo Logroscino, Daniele Urso, Rodolfo Savica
Neuroepidemiology (2022) Vol. 56, Iss. 5, pp. 309-318
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The impact of air pollution on neurodegenerative diseases: a narrative review of current evidence
Nicholas Aderinto, Ayobami Ajagbe, Gbolahan Olatunji, et al.
The Egyptian Journal of Internal Medicine (2025) Vol. 37, Iss. 1
Open Access | Times Cited: 1
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 6
Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
Oliver Daniel Schreiner, Thomas Gabriel Schreiner
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 14
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease
Manuela Dicarlo, Patrizia Pignataro, Chiara Zecca, et al.
Annals of Neurology (2024) Vol. 96, Iss. 1, pp. 61-73
Open Access | Times Cited: 5
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Belén Calvo, Pierre Schembri-Wismayer, María Beatriz Durán Alonso
Cells (2025) Vol. 14, Iss. 5, pp. 347-347
Open Access
Riluzole-loaded lipid nanoparticles for brain delivery: Preparation, optimization and characterization
Maria Inês Teixeira, Carla M. Lopes, Hugo Gonçalves, et al.
Journal of Molecular Liquids (2023) Vol. 388, pp. 122749-122749
Open Access | Times Cited: 11
The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need
Shu Wang, Yin Jiang, Anchao Yang, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease
Osama A. Mohammed, Mohammed S. Elballal, Ahmed A. El-Husseiny, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155023-155023
Closed Access | Times Cited: 10
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
(2024)
Open Access | Times Cited: 3
Recent developments in selective therapeutic targeting of functionalized nanomaterials to neurovascular units in overcoming the gaps in neurovascular therapy
Sakshi Goswami, Н. К. Исаев, Vladimir V. Salmin, et al.
Brain Disorders (2024) Vol. 15, pp. 100162-100162
Open Access | Times Cited: 3
The Role of Microbial Metabolites in the Progression of Neurodegenerative Diseases—Therapeutic Approaches: A Comprehensive Review
Jorge Missiego-Beltrán, Ana Isabel Beltrán-Velasco
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10041-10041
Open Access | Times Cited: 3
The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases
Francesca Bosco, Stefano Ruga, Rita Citraro, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3428-3428
Open Access | Times Cited: 7
INVASIVE PLANTS AS A SUSTAINABLE SOURCE OF BIOMOLECULES AGAINST NEURODEGENERATIVE DISEASES
Ana Ferreira da Vinha, Marta Isabel de Oliveira Soares
International Journal of Health Science (2024) Vol. 4, Iss. 16, pp. 2-10
Open Access | Times Cited: 2
Vocal Fold Motion Impairment in Neurodegenerative Diseases
Rumi Ueha, Cathrine Miura, Naoyuki Matsumoto, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2507-2507
Open Access | Times Cited: 2
The Impact of Caregiver Affiliate Stigma on the Psychosocial Well-Being of Caregivers of Individuals with Neurodegenerative Disorders: A Scoping Review
Nelly Becerra Carrillo, Massimo Guasconi, Serena Barello
Healthcare (2024) Vol. 12, Iss. 19, pp. 1957-1957
Open Access | Times Cited: 2
Oxytocin as neuro-hormone and neuro-regulator exert neuroprotective properties: A mechanistic graphical review
Roya Kamrani-Sharif, A. Wallace Hayes, Mina Gholami, et al.
Neuropeptides (2023) Vol. 101, pp. 102352-102352
Closed Access | Times Cited: 6
Amyotrophic Lateral Sclerosis—The Complex Phenotype—From an Epidemiological Perspective: A Focus on Extrapyramidal and Non-Motor Features
Daniele Urso, Stefano Zoccolella, Valentina Gnoni, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2537-2537
Open Access | Times Cited: 9
Management of Dysphagia in Neurodegenerative Disease
Jenni Wu, Ryan Burdick, Celia Deckelman, et al.
Current Otorhinolaryngology Reports (2023) Vol. 11, Iss. 3, pp. 352-364
Closed Access | Times Cited: 5
Accuracy of clinical diagnosis of behavioural variant frontotemporal dementia: a protocol for a systematic review and meta-analysis
Daniele Urso, Stefano Giannoni‐Luza, Stefania Mondello, et al.
BMJ Open (2024) Vol. 14, Iss. 7, pp. e081935-e081935
Open Access | Times Cited: 1
Neurodegeneration: can metabolites from Eremurus persicus help?
Valeria Cavalloro, Nicoletta Marchesi, Pasquale Linciano, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Inflammasomes in neurodegenerative diseases
Qianchen Wang, Songwei Yang, Xuan Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Oxidation-labile linkers for controlled drug delivery
Aitor Carneiro, Lourdes Santana, María João Matos
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 87, pp. 129264-129264
Open Access | Times Cited: 3
The Effect of <em>Andrographis paniculata</em> and Its Derivatives in Neurodegenerative Diseases and Neuroinflammation
Francesca Bosco, Stefano Ruga, Rita Citraro, et al.
(2023)
Open Access | Times Cited: 2
Pangenomics: A new era in the field of neurodegenerative diseases
Paolo Abondio, Francesco Bruno, Giuseppe Passarino, et al.
Ageing Research Reviews (2023) Vol. 94, pp. 102180-102180
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top